106 related articles for article (PubMed ID: 24908)
1. Significance of HLA and non-HLA antigens in bone marrow transplantation.
Opelz G; Gale RP; Feig SA; Walker J; Terasaki PI; Saxon A
Transplant Proc; 1978 Mar; 10(1):43-6. PubMed ID: 24908
[No Abstract] [Full Text] [Related]
2. The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation.
van Rood JJ; van Leeuwen A; Goulmy E; Termijtelen A; Bradley BA; Brand A; Eernisse JG
Transplant Proc; 1978 Mar; 10(1):47-51. PubMed ID: 24909
[No Abstract] [Full Text] [Related]
3. Association of lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) with bone-marrow graft rejection in HLA-identical siblings.
Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
Transplant Proc; 1978 Jun; 10(2):433-4. PubMed ID: 354133
[No Abstract] [Full Text] [Related]
4. The detection of non-HLA antibodies and their possible role in bone marrow graft rejection.
Claas FH; van Rood JJ; Warren RP; Weiden PL; Su PJ; Storb R
Transplant Proc; 1979 Mar; 11(1):423-6. PubMed ID: 377669
[No Abstract] [Full Text] [Related]
5. Cytotoxicity against HLA-identical sibling lymphocytes: genetic determination and independent segregation of the antigenic system involved.
Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
Transplant Proc; 1978 Mar; 10(1):67-9. PubMed ID: 345567
[No Abstract] [Full Text] [Related]
6. Cellular immunogenetics of HLA: quantitative crossmatches for LD and CD determinants.
Bach FH
Transplant Proc; 1978 Mar; 10(1):63-6. PubMed ID: 76353
[No Abstract] [Full Text] [Related]
7. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
[No Abstract] [Full Text] [Related]
8. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
Le Deist F; Raffoux C; Griscelli C; Fischer A
J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
[TBL] [Abstract][Full Text] [Related]
9. Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man.
Butturini A; Bortin MM; Seeger RC; Gale RP
Prog Clin Biol Res; 1987; 244():371-90. PubMed ID: 3310000
[TBL] [Abstract][Full Text] [Related]
10. Successful bone marrow transplantation in sensitized recipients.
Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F
Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-leukemia reactions following bone marrow transplantation for chronic myeloid leukemia.
Mackinnon S
Prog Clin Biol Res; 1992; 377():113-25; discussion 126-7. PubMed ID: 1438407
[No Abstract] [Full Text] [Related]
12. Non-HLA lymphocytotoxic antibodies during GVHD after bone marrow transplantation (BMT).
Gluckman E; Andersen E; Lepage V; Dausset J
Transplant Proc; 1977 Mar; 9(1):761-3. PubMed ID: 17200
[No Abstract] [Full Text] [Related]
13. Immunological reconstitution of a patient with severe combined immunodeficiency with bone marrow from the MLC matched but HLA-incompatible mother [proceedings].
Goldmann SF; Niethammer D; Haas RJ; Dietrich M; Flad HD; Stein G
Z Immunitatsforsch Immunobiol; 1976 Dec; 152(4):337-40. PubMed ID: 64042
[No Abstract] [Full Text] [Related]
14. The failure to demonstrate an involvement of human leukocyte group 5 antigens in graft-versus-host disease and marrow graft rejection.
Warren RP; Storb R; Nguyen DD; Thomas ED
Transplantation; 1977 Jul; 24(1):89-91. PubMed ID: 18823
[No Abstract] [Full Text] [Related]
15. Bone marrow transplantation.
Med Lett Drugs Ther; 1978 Nov; 20(22):98-100. PubMed ID: 30036
[No Abstract] [Full Text] [Related]
16. Severe combined immunodeficiency: transplantation approaches for patients lacking an HLA genotypically identical sibling.
O'Reilly RJ; Pahwa R; Dupont B; Good RA
Transplant Proc; 1978 Mar; 10(1):187-99. PubMed ID: 345560
[No Abstract] [Full Text] [Related]
17. Histocompatibility and marrow transplantation.
Hansen JA; Clift RA; Thomas ED; Buckner CD; Mickelson EM; Storb R
Transplant Proc; 1979 Dec; 11(4):1924-9. PubMed ID: 43613
[No Abstract] [Full Text] [Related]
18. Prognostic value of antibody-dependent assays for presensitization in bone marrow transplant recipients.
Parkman R; Rappeport J; Camitta B; Levey R; Rosen FS
Transplant Proc; 1978 Mar; 10(1):71-3. PubMed ID: 345568
[No Abstract] [Full Text] [Related]
19. Biological significance of Ss (serum soluble) HLA-class I antigens in bone marrow transplantation.
Tsuji K; Kusama M; Nakatsuji T; Kato S
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):169-74. PubMed ID: 2939598
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Bone marrow transplantation.
Can Med Assoc J; 1975 Feb; 112(3):270. PubMed ID: 234027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
